Y, S., P, S., MPM, L., JJWM, J., EFM, P., CL, B., . . . NMA, B. (2025). Patient-reported toxicity symptoms during tyrosine kinase inhibitor treatment in chronic myeloid leukemia: A systematic review and meta-analysis. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 33(5), 446. https://doi.org/10.1007/s00520-025-09451-4
Chicago Style (17th ed.) CitationY, Smit, Scheuter P, Lange MPM, Janssen JJWM, Posthuma EFM, Bekker CL, Hermens RPMG, and Blijlevens NMA. "Patient-reported Toxicity Symptoms During Tyrosine Kinase Inhibitor Treatment in Chronic Myeloid Leukemia: A Systematic Review and Meta-analysis." Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer 33, no. 5 (2025): 446. https://doi.org/10.1007/s00520-025-09451-4.
MLA (9th ed.) CitationY, Smit, et al. "Patient-reported Toxicity Symptoms During Tyrosine Kinase Inhibitor Treatment in Chronic Myeloid Leukemia: A Systematic Review and Meta-analysis." Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer, vol. 33, no. 5, 2025, p. 446, https://doi.org/10.1007/s00520-025-09451-4.